...ALK immunohistochemistry and molecular assays, may be essential for accurate diagnosis.
...ALK expression and the prognosis of elderly NSCLC patients after surgery. Therefore, the aim of this study is to investi...
...ALK gene rearrangement. Antitumor treatments such as lorlatinib can cause cardiac and metabolic complications, which has...
...ALK and NTRK rearrangements, particularly in systemic or extracutaneous disease. We evaluated an immunohistochemistry (I...
...ALK fusions (5.7%), ERBB2 exon 20 (4.8%), KRAS G12C (3.5%), MET exon 14 skipping (2.9%), and BRAF V600E and ROS1 (1.9% e...
...alkib and she died less than one month later. We reported a rare case of EML4-ALK fusion-positive LUSCC with a short-ter...
...ALK, along with immunotherapy using programmed cell death protein 1 (PD-1)/programmed death ligand 1 (PD-L1) inhibitors,...
...ALK) expression. It typically presents as rapidly growing nodules or tumors with a tendency to ulcerate, but often has a...
...ALK)-positive small bowel IMT detected by capsule endoscopy (CE). A 24-year-old woman presented with epigastric pain. Co...
...ALK in anaplastic large cell lymphoma (ALCL), and ETV6-NTRK3 in multiple tumor types. IL1RAP expression rendered these m...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269